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Relationship between Maternal Serum C-Reactive Protein, 
Funisitis and Early-Onset Neonatal Sepsis
The aim of this study was to determine whether maternal serum C-reactive protein (CRP) is 
of value in predicting funisitis and early-onset neonatal sepsis (EONS) in women with 
preterm labor or preterm premature rupture of membranes (PROM). This retrospective 
cohort study included 306 consecutive women with preterm labor or preterm PROM who 
delivered preterm singleton neonates (23-35 weeks gestation) within 72 hr of CRP 
measurement. The CRP level was measured with a highly sensitive immunoassay. The 
sensitivity, specificity, positive predictive value, and negative predictive value of an 
elevated serum CRP level (≥ 8 mg/L) were 74.1%, 67.5%, 32.8%, and 92.4% for funisitis, 
and 67.7%, 63.3%, 17.2%, and 94.6% for EONS, respectively. Logistic regression analysis 
demonstrated that elevated levels of serum CRP were significantly associated with funisitis 
and EONS, even after adjusting gestational age. The maternal serum CRP level obtained up 
to 72 hr before delivery is an independent predictor of funisitis and EONS in women with 
preterm labor or preterm PROM. A low serum CRP level (< 8 mg/L) has good negative 
predictive value in excluding funisitis and EONS, and may therefore be used as a non-
invasive adjunct to clinical judgment to identify low-risk patients.
Key Words: C-Reactive Protein; Early-Onset Neonatal Sepsis; Funisitis; Preterm Labor; 
Preterm Premature Rupture of Membrane
Sung Youn Lee
1, Kyo Hoon Park
1, 
Eun Ha Jeong
1, Kyung Joon Oh
1, 
Aeli Ryu
1, and Kyoung Un Park
2
Departments of 
1Obstetrics and Gynecology, and 
2Laboratory Medicine, Seoul National University 
College of Medicine, Seoul National University 
Bundang Hospital, Seongnam, Korea
Received: 16 July 2011
Accepted: 13 March 2012
Address for Correspondence:
Kyo Hoon Park, MD
Department of Obstetrics and Gynecology, Seoul National 
University Bundang Hospital, 82 Gumi-ro, Bundang-gu, 
Seongnam 463-707, Korea
Tel: +82.31-787-7252, Fax: +82.31-787-4054
E-mail: pkh0419@snubh.org
http://dx.doi.org/10.3346/jkms.2012.27.6.674  •  J Korean Med Sci 2012; 27: 674-680
ORIGINAL ARTICLE
Obstetrics & Gynecology
INTRODUCTION
Microbial invasion of the amniotic cavity (MIAC) is considered 
to be the leading cause of preterm labor or preterm premature 
rupture of membranes (PROM), with an incidence of approxi-
mately 25% of all preterm births (1, 2). A subset of fetuses ex-
posed to microorganisms in utero may elicit the fetal inflam-
matory response syndrome, including funisitis, which has been 
implicated as a cause of fetal or neonatal injury that leads to ce-
rebral palsy and chronic lung disease (1, 3-6). Similarly, in the 
setting of MIAC a substantial number of preterm neonates are 
born with congenital sepsis, which has a high lethality rate (7) 
and survivors are at risk for other complications, such as severe 
retinopathy of prematurity or periventricular leukomalacia (8, 
9). Therefore, the early identification of funisitis and congenital 
sepsis is a desirable clinical goal because a late diagnosis with 
delayed treatment of these early-onset diseases may increase 
the possibility of long-term sequelae and disability. 
  The early prenatal diagnosis of funisitis and/or congenital 
sepsis is difficult to achieve because the diagnosis of funisitis can 
only be made with certainty after delivery of the placenta and 
the diagnosis of congenital sepsis requires invasive procedures, 
such as cordocentesis. Therefore, several studies have attempt-
ed to develop sensitive and specific diagnostic parameters for 
funisitis and congenital sepsis via analysis amniocentesis-ob-
tained amniotic fluid (AF), such as the AF white blood cell count 
and cytokine levels, and such parameters have accordingly been 
reported as significant predictors (10-15); however, amniocen-
tesis is also an invasive procedure with risks. A recent study has 
reported that the maternal serum interleukin-6 (IL-6) predicts 
individuals destined to develop funisitis up to 72 hr before de-
livery (16). Moreover, funisitis has been implicated as a valu-
able marker for early-onset neonatal sepsis (13, 17, 18). As IL-6 
is thought to be the primary trigger of C-reactive protein (CRP) 
release (19), it follows that the maternal serum CRP can also be 
predictive of funisitis and early-onset neonatal sepsis. This in-
formation is clinically relevant because measurement of CRP is 
a non-invasive, rapid, inexpensive, and widely available test for 
detecting inflammation and tissue damage. The purpose of the 
current study, therefore, was to determine the diagnostic accu-
racy of the maternal serum CRP for the prediction of funisitis 
and early-onset neonatal sepsis in women with preterm labor 
or preterm premature rupture of membranes. 
MATERIALS AND METHODS
Study design
This retrospective cohort study consisted of consecutive wom-Lee SY, et al.  •  C-Reactive Protein Predicting Funisitis and Neonatal Sepsis
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en who were admitted to the Seoul National University Bun-
dang Hospital between January 2004 and December 2010 with 
the diagnosis of preterm labor and intact membranes or pre-
term PROM (gestational age  < 36 weeks) who met the follow-
ing criteria: 1) singleton gestation; 2) maternal blood drawn for 
determination of CRP levels on admission and weekly thereaf-
ter until delivery; 3) gestational age at birth  > 23.0 weeks and 
< 36.0 weeks; 4) placental histopathologic examination after 
preterm delivery; 5) absence of a major congenital anomaly; 6) 
delivery within 72 hr of CRP measurement. This last criterion 
was used to preserve a meaningful temporal relationship be-
tween the CRP level, placental histology, and neonatal outcome. 
Throughout the study period, the maternal serum CRP level was 
routinely measured at the time of admission in women who 
were diagnosed with preterm labor or preterm PROM. It is the 
policy at our institution to send the placenta of all preterm ba-
bies for histopathologic examination. 
Data storage and retrieval
A detailed database of all obstetric patients and neonates ad-
mitted to the neonatal intensive care unit at our institution has 
been maintained since 2004. Demographic, antenatal, delivery, 
and outcome information data for all preterm births are entered 
prospectively by research fellows and research assistants. The 
cohort data retrieved in the database includes maternal age, par-
ity, gestational age at the time of admission and delivery, gender, 
mode of delivery, causes of preterm birth (preterm labor and pre-
term PROM), maternal serum CRP on admission, birth weight, 
Apgar scores at 1 and 5 min, clinical diagnosis of chorioamnio-
nitis, placental pathologic diagnoses, antenatal use of medica-
tions (steroids and antibiotics), and the diagnosis of early-onset 
neonatal sepsis. The serum CRP levels, measured again at week-
ly intervals after admission, were abstracted from the electronic 
medical record in those patients who met entry criteria. 
Definition of terminology
Preterm labor was defined as the presence of regular uterine 
contractions with a frequency of at least 2 every 10 min and cer-
vical change that required hospitalization. Rupture of mem-
branes was diagnosed by a sterile speculum examination con-
firming both pooling of amniotic fluid in the vagina and a posi-
tive nitrazine test. Corticosteroids and antibiotics were started  
if indicated. Clinical chorioamnionitis was defined as a body 
temperature  ≥ 37.8°C on 2 occasions at least 4 hr apart, and 
> 2 of the following criteria: uterine tenderness; malodorous 
vaginal discharge; maternal leukocytosis (> 15,000/μL); mater-
nal tachycardia (> 100 beats/min); and fetal tachycardia (> 160 
beats/min) (20). Histologic chorioamnionitis was diagnosed in 
the presence of acute inflammatory changes in any of the tissue 
samples (amnion, chorion-decidua, umbilical cord, and chori-
onic plate) using criteria published previously (11). Funisitis was 
diagnosed in the presence of neutrophil infiltration into the um-
bilical vessel walls or Wharton’s jelly. Early-onset neonatal sep-
sis was defined as the presence of confirmed or suspected sepsis 
at  ≤ 72 hr after birth. Confirmed sepsis was diagnosed when ei-
ther the blood culture and/or cerebrospinal fluid culture was 
positive. Suspected sepsis was diagnosed in the absence of a 
positive culture when two or more of the following previously 
validated hematologic criteria (21, 22) were observed: absolute 
neutrophil count  < 7,500/μL or  > 14,500/μL; absolute band 
count  > 1,500/μL; immature/total neutrophil ratio  > 0.16; and 
platelet count  < 150,000/μL. 
C-reactive protein measurements 
The CRP level was measured with a latex-enhanced turbidimet-
ric immunoassay (Denka Seiken, Tokyo, Japan) using an auto-
mated analyzer (Toshiba 200FR; Toshiba, Tokyo, Japan). The 
detection limit of this assay is 0.1 mg/L. Both intra- and inter-
assay coefficients of variation were  < 10%. 
Statistical analysis
A Student’s t-test or Mann-Whitney U-test was used for com-
parison of continuous variables. Comparisons of proportions 
were performed with a chi-squared-test or Fisher’s exact test. 
Shapiro-Wilk and Kolmogorov-Smirnov tests were used to test 
for normal distribution of the data. A receiver operating charac-
teristic (ROC) curve analysis was used to determine the relation-
ship between the sensitivity (true-positive rate) and the false-
positive rate, and to select the best cut-off value for the serum 
CRP in the prediction of funisitis and early-onset neonatal sep-
sis. Diagnostic indices were calculated (sensitivity, specificity, 
positive predictive value [PPV], negative predictive value [NPP], 
positive likelihood ratio [LR+], and negative likelihood ratio [LR-]) 
for the serum CRP to identify funisitis and early-onset neonatal 
sepsis. A logistic regression analysis was performed to determine 
the relationship between serum CRP levels and the occurrence 
of funisitis and early-onset neonatal sepsis after adjusting for 
baseline variables that have a significant correlation or a ten-
dency with each of the outcome variables (P < 0.15), including 
gestational age, clinical chorioamnionitis, use of antenatal ste-
roids and use of antenatal antibiotics (Table 1). In the logistic 
regression model, all factors were entered as dichotomous vari-
ables and the ROC curves were used to identify the best cut-off 
values for the dichotomization of variables. All reported P val-
ues were two-sided, and P values  < 0.05 were considered sta-
tistically significant. SPSS 15.0 for Windows (SPSS Inc., Chicago, 
IL, USA) was used for statistical analyses. 
Ethics statement
The study protocol was reviewed and approved by the institu-
tional review board of the Seoul National University Bundang 
Hospital (IRB No. B-1006/103-102). Informed consent was waived Lee SY, et al.  •  C-Reactive Protein Predicting Funisitis and Neonatal Sepsis
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by the board due to retrospective approach of this study. 
RESULTS
Study population
During the study period, 514 women with a viable singleton preg-
nancy initially diagnosed with preterm labor or preterm PROM 
delivered between 23.1 and 35.6 weeks gestation. Of these 514 
women, 3 (0.6%) were excluded due to neonatal deaths in the 
delivery room, 1 (0.2%) for major congenital malformations, 
and 117 (23%) for an incomplete data set (lack of placental pa-
thology [n = 15] and lack of maternal serum CRP level on ad-
mission, or thereafter at weekly intervals until delivery [n = 102]). 
Eighty-seven additional women were excluded because of CRP 
measurement-to-delivery intervals  > 72 hr. The remaining 306 
women, who fit the study criteria, defined the study cohort:  
106 women had preterm labor with intact membranes and 200 
women had preterm PROM. No significant differences were 
noted between women with preterm PROM and intact mem-
branes with respect to the mean CRP level and the rates of clini-
cal chorioamnionitis and early-onset neonatal sepsis. However, 
women with preterm labor had a significantly lower gestational 
age at the time of admission and delivery and a higher rate of 
histologic chorioamnionitis than did women with preterm PROM 
(gestational age at delivery, 31.9 ± 2.9 vs 32.7 ± 2.8 weeks, P =  
0.031; rate of histologic chorioamnionitis, 54.7% [58/106] vs 
42% [84/200], P = 0.034). The reasons for not measuring CRP 
included immediate delivery following hospital admission and 
attending physician preference for the follow-up CRP measure-
ments.  
  Funisitis was present in 17.6% of the cases (54/306) and ear-
ly-onset neonatal sepsis was diagnosed in 10.4% of the cases 
(31/306). Of 31 neonates with early-onset neonatal sepsis, 6.5% 
(2/31) were diagnosed based on blood culture results and 93.5% 
(29/31) were clinically suspected to have sepsis. Microorgan-
isms isolated from blood cultures included coagulase-negative 
Table 1. Demographic and clinical characteristics of women and their newborns       
according to the presence or absence of funisitis
Characteristics
Funisitis
P value Absent 
(n = 252)
Present 
(n = 54)
Maternal characteristics at 
  admission and hospital course
   Maternal age (yr)
   Nulliparity
   Gestational age at admission (weeks)
   Cause of preterm delivery
       Preterm labor
       Preterm PROM
   Antenatal antibiotics use
   Antenatal corticosteroid use
   Clinical chorioamnionitis
   Serum CRP (mg/L)
 
 
31.0 ± 4.1
131 (52%)
32.3 ± 3.0
  
  91 (36%)
161 (64%)
175 (69%)
122 (48%)
  7 (3%)
  10.9 ± 17.9
 
 
31.9 ± 3.5
27 (50%)
29.7 ± 3.4
  
15 (28%)
39 (72%)
47 (87%)
40 (74%)
14 (26%)
  21.9 ± 17.3
 
 
0.177
0.791
< 0.001
0.243
0.009
0.001
< 0.001
< 0.001
Outcome characteristics
   Gestational age at delivery (weeks)
   Cesarean delivery
   Birth weight (g)
   Male fetus
   Apgar score  < 7
      1 min
      5 min
   Histologic chorioamnionitis
   Early-onset neonatal sepsis
 
 32.9 ± 2.6
  89 (35%)
 2,051 ± 564
154 (61%)
  
  97 (39%)
  37 (15%)
  89 (35%)
20 (8%)
 
30.5 ± 3.2
16 (30%)
1,629 ± 581
31 (57%)
  
29 (54%)
14 (26%)
53 (98%)
11 (20%)
 
< 0.001
0.424
< 0.001
0.613
  
0.039
0.044
< 0.001
0.006
Values are given as the mean ± standard deviation or No. (%). PROM, premature rup-
ture of membranes; CRP, C-reactive protein.
Fig. 1. Receiver operating characteristic (ROC) curves for maternal serum C-reactive protein (CRP). (A) For predicting funisitis. Numbers next to solid dots represent serum CRP 
levels (mg/L; area under the curve, 0.751; SE, 0.036; P < 0.001). (B) For predicting early-onset neonatal sepsis. Numbers next to solid dots represent serum CRP levels (mg/L; 
area under the curve, 0.700; SE, 0.051; P < 0.001).
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Staphylococcus (n = 1) and Acinetobacter baumannii (n = 1). 
Relationship between serum CRP and funisitis
Table 1 shows the demographic and clinical characteristics of 
the women and their newborns according to the presence or ab-
sence of funisitis. Women with funisitis had a significantly lower 
mean gestational age at the time of admission and delivery, high-
er rates of clinical chorioamnionitis and histologic chorioamni-
onitis, were more likely to receive antenatal antibiotics and cor-
ticosteroids, and were more likely to deliver neonates with ear-
ly-onset neonatal sepsis than women without funisitis. Howev-
er, there were no significant differences in the mean maternal 
age and the distribution of women with preterm PROM and in-
tact membranes between these two groups. The mean serum 
CRP levels were significantly higher in women with funisitis 
than in women without funisitis. 
  Fig. 1A is a ROC curve describing the values of the serum CRP 
levels in predicting funisitis. The curve constructed for the ma-
ternal serum CRP was above the 45° line, indicating a significant 
relationship with funisitis (area under the curve [AUC], 0.751; 
standard error [SE], 0.036; P < 0.001). The best cut-off value for 
CRP to predict funisitis was 8 mg/L. The sensitivity, specificity, 
PPV, NPV, LR+, and LR- of an elevated serum CRP level (≥ 8 mg/ 
L) to predict funisitis are shown in Table 2.
  To control for the significant differences in gestational age at 
the time of delivery, clinical chorioamnionitis, use of antenatal 
steroids, and use of antenatal antibiotics, we performed logistic 
regression analysis. Using the cut-off values derived from the 
ROC curves, elevated levels (≥ 8 mg/L) of maternal serum CRP 
were significantly associated with funisitis, even after control-
ling for gestational age, chorioamnionitis, use of antenatal ste-
roids, and use of antenatal antibiotics (odds ratio [OR], 4.44, 95% 
confidence interval [CI] 2.11-9.34; Table 3).
Relationship between serum CRP and early-onset 
neonatal sepsis
Table 4 describes the demographic and clinical characteristics 
Table 2. Diagnostic indices of different C-reactive protein levels in the prediction of funisitis and early-onset neonatal sepsis
Sensitivity (% [n]) Specificity (% [n]) PPV (% [n]) NPV (% [n]) LR+ (95% CI) LR- (95% CI)
CRP  ≥ 4 mg/L
   Funisitis
   Early-onset neonatal sepsis
  
88.9 (48/54)
83.9 (26/31)
  
41.3 (104/252)
38.2 (105/275)
  
24.5 (48/196)
13.3 (26/196)
  
94.5 (104/110)
95.5 (105/110)
  
1.51 (1.32-1.74)
1.36 (1.13-1.63)
  
0.27 (0.13-0.58)
0.42 (0.19-0.96)
CRP  ≥ 8 mg/L
   Funisitis 
   Early-onset neonatal sepsis
  
74.1 (40/54)
 67.7 (21/31)
  
67.5 (170/252)
63.3 (174/275)
  
32.8 (40/122)
17.2 (21/122)
  
92.4 (170/184)
94.6 (174/184)
  
2.28 (1.80-2.89)
1.84 (1.38-2.46)
  
0.38 (0.24-0.61)
0.51 (0.30-0.86)
CRP  ≥ 12 mg/L
   Funisitis 
   Early-onset neonatal sepsis
  
59.3 (32/54)
54.8 (17/31)
  
77.4 (195/252)
73.8 (203/275)
  
36.0 (32/89)
19.1 (17/89)
  
89.9 (195/217)
93.5 (203/217)
  
2.62 (1.91-3.60)
2.10 (1.44-3.05)
  
0.53 (0.38-0.73)
0.61 (0.41-0.91)
CRP  ≥ 20 mg/L
   Funisitis
   Early-onset neonatal sepsis
  
48.1 (26/54)
41.9 (13/31)
  
86.9 (219/252)
83.3 (229/275)
  
44.1 (26/59)
22.0 (13/59)
  
88.7 (219/247)
92.7 (229/247)
  
3.68 (2.41-5.61)
2.51 (1.53-4.10)
  
0.60 (0.46-0.78)
0.70 (0.52-0.95)
PPV, positive predictive value; NPV, negative predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; CI, confidence interval; CRP, C-reactive protein.
Table 4. Demographic and clinical characteristics of women and their newborns       
according to the presence or absence of early-onset neonatal sepsis
Characteristics
Early-onset neonatal sepsis
 P value Absent 
(n = 275)
Present 
(n = 31)
Maternal characteristics at 
  admission and hospital course
   Maternal age (yr)
   Nulliparity
   Gestational age at admission (weeks)
   Cause of preterm delivery
      Preterm labor
      Preterm PROM
   Antenatal antibiotics use
   Antenatal corticosteroid use
   Clinical chorioamnionitis
   Serum CRP (mg/L)
 
 
31.2 ± 4.1
142 (52%)
32.0 ± 3.2
 
  96 (35%)
179 (65%)
201 (73%)
145 (53%)
14 (5%)
  11.0 ± 13.9
 
 
31.2 ± 2.7
16 (52%)
30.3 ± 3.6
 
10 (32%)
21 (68%)
21 (68%)
17 (55%)
  7 (23%)
  28.7 ± 36.8
 
 
0.921
0.998
0.011
0.769
 
 
0.527
0.823
< 0.001
< 0.001
Outcome characteristics
   Gestational age at delivery (weeks)
   Cesarean delivery
   Birth weight (g)
   Male fetus
   Apgar score  < 7
       1 min
       5 min
   Histologic chorioamnionitis
   Funisitis
   
32.6 ± 2.7
  90 (33%)
2,118 ± 573
167 (61%)
  
105 (38%)
  38 (14%)
123 (45%)
  43 (16%)
   
30.8 ± 3.4
15 (48%)
1,614 ± 609
18 (58%)
  
21 (68%)
13 (42%)
19 (61%)
11 (36%)
  
0.003
0.082
0.001
0.774
  
0.002
< 0.001
0.08
0.006
Values are given as the mean ± standard deviation or No. (%). PROM, premature rup-
ture of membranes; CRP, C-reactive protein.
Table 3. Logistic regression analyses of independent variables in predicting funisitis 
and early-onset neonatal sepsis 
Variables  Odds ratio 95% CI  P value
Funisitis
   CRP  ≥ 8 mg/L
   Gestational age at delivery  ≤ 32 weeks
   Antenatal antibiotics  
   Antenatal corticosteroids
   Clinical chorioamnionitis
 
4.44
2.74 
3.03
1.27
6.97
 
2.11-9.34
1.25-6.03
1.16-7.88
0.55-2.93
2.41-20.2
 
< 0.001
0.012
0.023
0.569
< 0.001
Early-onset neonatal sepsis
   CRP  ≥ 8 mg/L
   Gestational age at delivery  ≤ 32 weeks
   Clinical chorioamnionitis
 
2.81
1.55
3.65
 
1.21-6.51
0.68-3.57
  1.26-10.56
 
0.016
0.298
0.017
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of the women and their newborns according to the presence or 
absence of early-onset neonatal sepsis. Women who delivered 
neonates with early-onset neonatal sepsis had a lower mean 
gestational age at the time of admission and significantly higher 
rates of clinical chorioamnionitis and funisitis when compared 
with women delivering neonates without early-onset neonatal 
sepsis. Neonates with early-onset neonatal sepsis were delivered 
earlier and had a lower mean birth weight and lower Apgar scores 
compared with those without early-onset neonatal sepsis. How-
ever, there were no significant differences in the mean maternal 
age, the prevalence of histologic chorioamnionitis, and the pro-
portion of mothers receiving antenatal antibiotics or corticoste-
roids between mothers of neonates with early-onset neonatal 
sepsis compared with those who delivered without sepsis. The 
mean serum CRP levels were significantly higher in women de-
livering neonates with early-onset neonatal sepsis than women 
delivering neonates without early-onset neonatal sepsis. 
  A ROC curve was constructed and used to select cut-off val-
ues to dichotomize serum CRP levels as being increased or not 
increased (AUC, 0.700; SE, 0.051; P < 0.001; Fig. 1B). A cut-off 
value of 8 mg/L for serum C-reactive protein appeared to repre-
sent a reasonable compromise between the sensitivity and spec-
ificity, and was then used to calculate diagnostic indices for the 
prediction of early-onset neonatal sepsis. The sensitivity, speci-
ficity, PPV, NPV, LR+, and LR- to predict early-onset neonatal 
sepsis are shown in Table 2. To determine the significant inde-
pendent predictive effect of CRP on early-onset neonatal sepsis, 
logistic regression analysis was performed. Based on this model, 
an elevated CRP level (≥ 8 mg/L) was significantly associated 
with early-onset neonatal sepsis after adjustment for gestation-
al age at delivery and clinical chorioamnionitis (OR, 2.81; 95% 
CI, 1.21-6.51; Table 3). 
DISCUSSION
A number of studies have assessed the relationship between 
early-onset neonatal sepsis and the maternal serum CRP level; 
some studies have demonstrated a significant association (12, 
23, 24), while other studies have failed to do so (25, 26). This dis-
crepancy among studies is probably attributable, in part, to a 
wide variety of time intervals between CRP measurement and 
delivery. Indeed, a recent study in which daily blood samples 
were collected from women with preterm PROM revealed that 
maternal serum IL-6 rises as much as 72 hr before the onset of 
labor or clinical infection (16). Therefore, the current study was 
restricted to the women who delivered within 72 hr of the CRP 
measurement, so that the CRP measurement, neonatal outcome, 
and histologic examination of the placenta could be compared 
in a temporally meaningful way, and showed that CRP measure-
ment independently predicted early-onset neonatal sepsis. Nev-
ertheless, in the current study the AUC for the maternal serum 
CRP was relatively small (95% CI, 0.600-0.800) and the likeli-
hood ratio was 1.84, which suggests that the usefulness of se-
rum CRP alone as a predictor of early-onset neonatal sepsis is 
limited. These findings are in agreement with the recent study 
by van der Heyden et al. (24). 
  From a practical point of view, we propose that the maternal 
serum CRP level can be used as a screening test for early-onset 
neonatal sepsis and funisitis rather than a diagnostic test. Spe-
cifically, screening for early-onset neonatal sepsis and funisitis 
would begin with a maternal serum CRP measurement which 
can classify women with preterm labor or preterm PROM into 
high- and low-risk groups, and those at high-risk could then be 
targeted for appropriate risk-specific intervention (e.g., amnio-
centesis).
  A maternal serum CRP  < 8 mg/L has good negative predic-
tive value for early-onset neonatal sepsis and funisitis, suggest-
ing that a low CRP can identify women and their newborns who 
may safely avoid overtreatment (e.g., antibiotics and invasive 
intervention). These findings are consistent with the reports by 
Kurki et al. (26) and Ernest et al. (27) who demonstrated that neg-
ative CRP values before delivery strongly suggest the absence of 
chorioamnionitis and/or neonatal infection. The current study 
showed that approximately 60% of patients presenting with pre-
term labor or preterm PROM will be included into this catego-
ry. This finding is supported in the literature, in which 67% of 
women presenting with preterm labor had a CRP  < 8 mg/L (28). 
CRP has the potential to accurately identify a significant portion 
of women presenting with preterm labor or preterm PROM as 
low risk for early-onset neonatal sepsis and funisitis. 
  Several investigators have reported that the maternal serum 
CRP is valuable for the early diagnosis of histologic chorioam-
nionitis in the absence of clinical signs of infection (10-12, 23). 
However, to date there have been no reports on maternal serum 
CRP levels in relation to funisitis. Our finding that serum CRP 
levels are related to funisitis is novel, but not unexpected be-
cause a similar relationship has been demonstrated with IL-6, 
the primary cytokine responsible for the biosynthesis of CRP (16). 
Indeed, a significant relationship between maternal serum IL-6 
and CRP level has been shown (29). 
  This is the first study to examine the independent predictive 
value of the maternal serum CRP level for funisitis. A fetal in-
volvement assessment is an important step in the management 
of infection-associated preterm labor or preterm PROM. The 
difficulty with this assessment has lead to development of a num-
ber of markers in umbilical cord plasma at birth and amniotic 
fluid. However, evaluating markers in these body fluids is rarely 
helpful in the early prediction of funisitis as access to these body 
fluids is limited in an ongoing pregnancy or may require the use 
of invasive techniques. In contrast, CRP test in maternal serum, 
as used in the current study, is non-invasive, inexpensive, and 
easily performed before delivery, thus allowing for serial test-Lee SY, et al.  •  C-Reactive Protein Predicting Funisitis and Neonatal Sepsis
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ing. Therefore, our finding that the serum CRP is independently 
predictive of funisitis can be beneficial to clinicians in counsel-
ing and clinical management of women with preterm labor or 
preterm PROM. 
  Our study had several limitations. First, the most important 
one is the retrospective design. However, most data (i.e., mater-
nal, placental, and other perinatal parameters) were collected 
prior to inclusion in the study by means of an electronically-pre-
pared Excel-based (Microsoft Corporation, Redmond, WA, USA) 
data collection tool. Thus, each data element was accurately 
documented and verified. Second, we included a heterogeneous 
group of women regarding the status of fetal membranes (e.g., 
intact or ruptured fetal membranes). However, we believe that 
our main results remain valid because elevated levels of serum 
CRP were significantly associated with both funisitis and early-
onset neonatal sepsis after adjustment for the confounding vari-
ables (gestational age, clinical chorioamnionitis, and the state 
of fetal membranes). 
  In conclusion, a maternal serum CRP level obtained up to 72 
hr before delivery is an independent predictor of funisitis and 
early-onset neonatal sepsis in women with preterm labor or 
preterm PROM but the usefulness is limited. A serum CRP level 
< 8 mg/L has a good negative predictive value in excluding fu-
nisitis and early-onset neonatal sepsis, and may therefore be a 
useful non-invasive adjunct to clinical judgment to identify low-
risk patients. These findings need to be replicated prospectively 
in a second larger cohort because a recent study has found a sig-
nificant influence of socio-demographic characteristics (e.g., 
race) on CRP values during normal pregnancy (30). 
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